MGTX Form 4: CEO sale of 47,500 shares via 10b5-1 plan
Rhea-AI Filing Summary
Insider sale by a senior officer: Alexandria Forbes, listed as President & CEO and a director, reported a sale of 47,500 ordinary shares of MeiraGTx Holdings plc (MGTX) on 10/07/2025. The sales were executed under a pre-established Rule 10b5-1 trading plan adopted on 08/21/2024.
The filing shows a weighted average sales price of $8.39, with individual trade prices ranging from $8.23 to $8.53. Following the reported disposition, the reporting person beneficially owns 1,313,983 ordinary shares.
Positive
- Sale executed under a Rule 10b5-1 plan adopted on 08/21/2024
- Weighted average sale price disclosed at $8.39, with price range provided
Negative
- Senior executive sold 47,500 shares, reducing direct holdings
- Post-transaction beneficial ownership remains at 1,313,983 shares (potentially dilutive signal to some investors)
Insights
Pre-planned sale reduces headline concern but remains notable given role.
The sale was executed under a Rule 10b5-1 plan adopted on 08/21/2024, which indicates the transactions were pre-scheduled rather than opportunistic. That structure commonly aims to provide an affirmative defense against insider trading claims when properly adopted and followed.
Key dependencies include the plan's terms and any blackout restrictions; investors can request details about per-price execution from the reporting person as the filing notes. Near-term monitoring should focus on any additional Form 4 filings or modifications to the trading plan.
Sale size, price range, and post-sale holdings are clearly disclosed.
The filing reports a 47,500 share disposition at a weighted average of $8.39, with prices between $8.23 and $8.53. The reporting person retains 1,313,983 shares after the transaction.
Because the filing commits to provide per-price breakdowns on request, interested parties can obtain exact execution details. Watch for further filings showing additional sales or plan terminations in the coming reporting periods.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 47,500 | $8.39 | $399K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $8.23 to $8.53, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
AI-generated analysis. How Rhea-AI works. Not financial advice.